Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells
Abstract The CRISPR/Cas9 system is a versatile tool for functional genomics and forward genetic screens in mammalian cells. However, it has been challenging to deliver the CRISPR components to sensitive cell types, such as primary human hematopoietic stem and progenitor cells (HSPCs), partly due to...
Guardado en:
Autores principales: | David Yudovich, Alexandra Bäckström, Ludwig Schmiderer, Kristijonas Žemaitis, Agatheeswaran Subramaniam, Jonas Larsson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/37fcffdd00f84de08d81d45c0b3fdfd6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Functional profiling of single CRISPR/Cas9-edited human long-term hematopoietic stem cells
por: Elvin Wagenblast, et al.
Publicado: (2019) -
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells
por: J. Boutin, et al.
Publicado: (2021) -
Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations
por: Clare Samuelson, et al.
Publicado: (2021) -
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
por: Asmamaw M, et al.
Publicado: (2021) -
Engineering of CRISPR-Cas12b for human genome editing
por: Jonathan Strecker, et al.
Publicado: (2019)